Trial NCT04745832

View at ClinicalTrials.gov 
Org. Study IDs: ME-401-004
Secondary IDs: 2020-004199-16

Last trial update was posted on 2023-12-13

MeSH Interventions

Bendamustine Hydrochloride Cyclophosphamide Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Non-Hodgkin

Other Conditions

Follicular Lymphoma (FL) Marginal Zone Lymphoma Non Hodgkin Lymphoma

Stopping Reasons

Discontinuation of zandelisib program

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID